Cited by 166Sleep and related disordersParkinson's Disease Mechanisms and TreatmentsCircadian rhythm and melatonin

Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson's disease – A randomized study

Rios Romenets, S., Creti, L., Fichten, C., Bailes, S., Libman, E., Pelletier, A., Postuma, R.B.·2013·Parkinsonism & Related Disorders

Abstract

Introduction Although a variety of pharmacologic and non-pharmacologic treatments are effective for insomnia in the general population, insomnia in Parkinson's disease differs in important ways and may need different treatments. No studies have conclusively demonstrated effective insomnia treatments in Parkinson's disease. Methods We conducted a three-arm six-week randomized pilot study assessing non-pharmacologic treatment (cognitive behavioural therapy with bright light therapy) or doxepin (10 mg daily), compared to an inactive placebo in Parkinson's patients with insomnia. Sleep outcomes included insomnia scales, clinical global impression, sleep diaries and actigraphy. Secondary outcomes included motor severity, fatigue, depression and quality of life. Results 18 patients were randomized, 6 to each group. Compared to placebo, doxepin improved the Insomnia Severity Index (-9 ± 5.4 vs. -2 ± 3.9, p = 0.03), the SCOPA-night score (-5.2 ± 1.5 vs. -2.3 ± 2.8, p = 0.049), the Pittsburgh Sleep Quality Index-sleep disturbances subscale (-0.5 ± 0.5 vs 0.2 ± 0.4, p = 0.02), and both patient and examiner-rated clinical global impression of change (1.7 ± 0.8 vs. 0.5 ± 0.8, p = 0.03 and 1.4 ± 0.5 vs. 0.3 ± 0.5, p = 0.003). On secondary outcomes doxepin reduced the fatigue severity scale (p = 0.02) and improved scores on the Montreal Cognitive Assessment (p = 0.007). Non-pharmacological treatment reduced the Insomnia Severity Index (-7.8 ± 3.8 vs. -2.0 ± 3.9, p = 0.03), and the examiner…

Integrity signals

Registry

Crossref · 10.1016/j.parkreldis.2013.03.003

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Four RCTs showed significant improvements in insomnia and sleep quality when comparing face-to-face or computerised CBT with education on basic sleep hygiene, sham light therapy, or TAU.

    “In particular, four RCTs showed significant improvements in participants' levels of insomnia and sleep quality when comparing face-to-face or computerised CBT with education on basic sleep hygiene (Leroi, Baker, Kehoe, Daniel, & Byrne, 2010; Patel et al., 2017), sham light therapy (Rios Romenets et al., 2013), or TAU (Kraepelien et al., 2020).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rios Romenets, S., Creti, L., Fichten, C., Bailes, S., Libman, E., Pelletier, A., & Postuma, R. B.
Affiliations
  • Jewish General Hospital (CA)
  • Research Institute of the McGill University Health Centre (CA)
  • Montreal General Hospital (CA)
Corresponding author
Postuma, R.B.
Venue
Parkinsonism & Related Disorders
Publisher
Elsevier BV
Published
2013-07
Volume
19
Issue
7
Pages
670-675
ISSN
1353-8020 (ISSN-L)
OpenAlex
W2061728401
Cited by
166
References
5
Citations by year
2026: 6 · 2025: 10 · 2024: 13 · 2023: 13 · 2022: 10 · 2021: 16 · 2020: 18 · 2019: 11 · 2018: 16 · 2017: 19 · 2016: 18 · 2015: 10 · 2014: 3 · 2013: 2
FWCI
14.87
Type
journal article
Language
en
Open access
closed
Locations
  • Parkinsonism & Related Disorders (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Canadian Institutes of Health Research
  • Parkinson Society Canada
  • Fonds de Recherche du Québec - Santé
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
Keywords
Parkinson's disease, insomnia
MeSH terms
Adult, Aged, Aged, 80 and over, Antidepressive Agents, Tricyclic, Doxepin, Female, Humans, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Parkinson Disease, Severity of Illness Index, Cognitive Behavioral Therapy, Treatment Outcome, Actigraphy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review